Johns Hopkins Bloomberg School of Public Health
Dr. Daniel Feikin has been with CDC for 15 years, where he spent 6 years with the Respiratory Diseases Branch focusing on bacterial pneumonia, particularly pneumococcus and Hib, in developing countries. From 2004,-2010, he served as the Epidemiology Section Chief for the International Emerging Infections Program in Kenya. There, Dr. Feikin worked on surveillance establishing the burden and epidemiology of respiratory and diarrheal illness, was co-PI on a rotavirus vaccine study, and conducted a carriage survey of pneumococcus before and after vaccine introduction. Since 2010, Dr. Feikin has served as the Epidemiology Section head at the International Vaccine Access Center at Johns Hopkins School of Public Health, where he has focuses on evaluations of childhood pneumonia etiology, serotype replacement after pneumococcal conjugate vaccine introduction, and demand side incentives to improving routine immunizations in Africa. Dr. Feikin did his clinic training in Internal Medicine at UCSF, received his MSPH at University of Colorado, and is a graduate of CDC’s EIS program.